Christopher Shen

  • Christopher Shen
  • Adjunct Professor, KGI
  • Qualification: PhD


Dr. Shen is currently a Scientist at Allergan where he works in microbial process development for biopharmaceutical production. Prior to Allergan, he was a postdoc at KGI under Matt Croughan, where he worked on CHO culture media supplementation and stem cell process development. He regularly teaches bioseparations at KGI as an Adjunct Professor.

Shen received his BS with high honors in Bioengineering from UC Berkeley and his PhD in Biomedical Engineering from the joint program at Georgia Institute of Technology and Emory University in 2011. He completed his PhD work on multifunctional nanoparticles for diagnostics and drug delivery under Shuming Nie.

ALS 429

Bioseparation Engineering and Science

Bioprocess engineering, including bioseparations, was and often still is a major skill set of professionals like brewers, winemakers, or in ancient times, wizards or sorcerers. Success in large-scale recombinant protein manufacturing is a recent manifestation of a long and glorious history of the field.

The primary goal of this course is to provide students with an advanced background in bioseparations science and engineering. Graduates in molecular biology, bioengineering, and many other fields can potentially take advantage of opportunities in pharmaceutical biotechnology, biotechnology development, manufacturing, commercial operations, quality assurance, regulatory affairs, business development, licensing, and investment fund management. To access such opportunities quickly and successfully, it is valuable to understand the basic principles of bioprocess engineering and to have an advanced background in a subspecialty or application area, such as fermentation, cell culture, and/or bioseparations. This type of knowledge and experience can be applied to a career in pharmaceutical biotechnology, and to other areas of biotechnology, such as biofuels.